Skip to search formSkip to main contentSkip to account menu

Bladder tumor Ag

Known as: Bladder tumor Antigen 
National Institutes of Health

Related topics

Related topics

4 relations
Bladder tumor Ag:ACnc:Pt:Urine:QnBladder tumor Ag:ACnc:Pt:Urine:Qn:IABladder tumor Ag:PrThr:Pt:Urine:OrdBladder tumor Ag:PrThr:Pt:Urine:Ord:IA

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
2012
2012
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria
We appraised 23 biomarkers previously associated with urothelial cancer in a case‐control study. Our aim was to determine whether… 
Highly Cited
2012
Highly Cited
2012
Urinary BTA: indicator of bladder cancer or of hematuria
BackgroundIn this study, we investigated the influence of hematuria on the performance of the bladder tumor antigen (BTA) tests… 
Highly Cited
2003
Highly Cited
2003
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.
OBJECTIVE To evaluate the veterinary version of the bladder tumor antigen (V-BTA) test as a screening test for transitional cell… 
2003
2003
Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection
BackgroundIn a prospective study we compared the usefulness of urinary nuclear matrix protein 22 (NMP22) with that of urine… 
Highly Cited
2002
Highly Cited
2002
The BTA stat test is nonspecific for hematuria: an experimental hematuria model.
2001
2001
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.
Highly Cited
1999
Highly Cited
1999
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Highly Cited
1999
Highly Cited
1999
Evaluation of Urinary Level of NMP22 as a Diagnostic Marker for Stage pTa-pT1 Bladder Cancer: Comparison with Urinary Cytology and BTA Test
Background: In the present study we compared the clinical value of two new specific tests for transitional cell carcinoma… 
Highly Cited
1996
Highly Cited
1996
Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)